Dr Felix Krendi, MD
The Mount Sinai Hospital, Recanati/Miller Transplantation Institute New York, USA

Dr Felix Julius Krendl is a transplant and hepatobiliary surgery fellow at the Recanati/Miller Transplantation Institute, Icahn School of Medicine at Mount Sinai, New York. He studied medicine at Ludwig Maximilian University of Munich and completed his specialist training in general and visceral surgery at the Medical University of Innsbruck. His clinical and research interests include liver transplantation, hepatobiliary surgery, organ preservation and transplant oncology.  

Dr Jeswanth Reddy
Rela Institute and Medical Centre, India

Dr Jeswanth Reddy is a medical gastroenterologist currently undertaking a Transplant Hepatology Fellowship at Rela Institute and Medical Centre, Chennai, under the LTSI Fellowship Programme. He completed his MD at JSS Academy of Higher Education and Research, Mysuru, and his DrNB in Medical Gastroenterology at Gleneagles Hospital, Chennai. He is developing specialist expertise in liver transplantation and hepatology within a high-volume liver transplant centre.

Surgery: 

Albert Chi-Yan Chan, MBBS, FRCS, FCSHK, FHKAM
The University of Hong Kong Li Ka Shing Faculty of Medicine, Hong Kong

Professor Albert Chi-Yan Chan is the Li Shu Fan Medical Foundation Professor in Surgery at the University of Hong Kong, Director of the Liver Transplant Centre at Queen Mary Hospital, and Co-Chief of Hepatobiliary and Pancreatic Surgery and Liver Transplantation. He specializes in living-donor liver transplantation, advanced hepatobiliary surgery, hepatocellular carcinoma and transplant oncology. Professor Chan pioneered the START-FIT multimodality strategy combining TACE, stereotactic radiotherapy and immunotherapy to downstage locally advanced HCC for surgery or transplantation. He also performed the world’s first pediatric ALPPS Professor Albert Chi-Yan Chan is the Li Shu Fan Medical Foundation Professor in Surgery at the University of Hong Kong, Director of the Liver Transplant Centre at Queen Mary Hospital, and Co-Chief of Hepatobiliary and Pancreatic Surgery and Liver Transplantation. He specializes in living-donor liver transplantation, advanced hepatobiliary surgery, hepatocellular carcinoma and transplant oncology. Professor Chan pioneered the START-FIT multimodality strategy combining TACE, stereotactic radiotherapy and immunotherapy to downstage locally advanced HCC for surgery or transplantation. He also performed the world’s first pediatric ALPPS procedure and the first liver histotripsy treatment in Asia. He is former President of the Asian Surgical Association and has published more than 300 peer-reviewed articles. 

Hepatology: 

Dr. Abid Suddle, MBBS, MD, FRCP
King’s College Hospital, London

Dr. Abid Suddle is a Consultant Hepatologist and Transplant Physician at the Institute of Liver Studies, King’s College Hospital in London. He specializes in hepatocellular carcinoma, chronic liver disease and liver transplantation and is a clinical lead within King’s multidisciplinary HCC service. Dr. Suddle is actively involved in clinical research, service development and medical education. He served as the lead author of the 2024 British Society of Gastroenterology guidelines for the management of hepatocellular carcinoma in adults, providing multidisciplinary recommendations covering surveillance, diagnosis, locoregional and systemic therapies, surgical treatment and liver transplantation.

IR: 

Sanjeeva Kalva, MBBS, MD, RPVI, FSIR, FCIRSE, FACR
University of Texas Southwestern Medical Center, Texas, USA

Professor Sanjeeva Kalva is Professor of Radiology and Vice Chair of Image-Guided Interventions at UT Southwestern Medical Center. He trained in diagnostic and interventional radiology in India before completing research and clinical fellowships in vascular and interventional radiology at Massachusetts General Hospital. He later served as Chief of Vascular and Interventional Radiology at Massachusetts General Hospital and Professor of Radiology at Harvard Medical School. His clinical and research expertise encompasses interventional oncology, liver-directed cancer therapy, portal-hypertension interventions, therapeutic embolization and pulmonary vascular malformations. He has authored more than 200 peer-reviewed publications and is a Fellow of SIR, CIRSE and the American College of Radiology. 

Oncology: 

Angela Lamarca MD, PhD, MSc
OncoHealth Institute, Fundación Jiménez Díaz University Hospital, Madrid

Dr Angela Lamarca is a Medical Oncologist (MD, PhD, MSc), specialised in gastrointestinal malignancies (hepato-pancreato-biliary (HPB) and neuroendocrine tumours (NETs)). She completed her training in Medical Oncology (including her PhD) in Spain (Hospital Universitario La Paz, Madrid). She moved to The Christie NHS Foundation Trust (Manchester, United Kingdom) in 2013, where she completed a 4-year fellowship programme in HPB and NETs. Dr Lamarca has completed a Masters Degree in Molecular Biology of Cancer and a second Masters Degree in Biostatistics. She was awarded with an American Society of Clinical Oncology (ASCO) Conquer Cancer Foundation Young Investigator Award in 2017 and was appointed as a Consultant in Medical Oncology at The Christie NHS Foundation Trust in May 2018 where she practiced until May 2022, when she moved back to Madrid (Spain; Fundacion Jimenez Diaz University Hospital) to continue her clinical and research activities in HPB and NETs, where she also acts as a Teaching Consultant at Autonomous University in Madrid (UAM). She has published more than 220 peer-review manuscripts, accounting for an H-index of 42 and more than 8,000 citations 

Dr Parissa Tabrizian MD, MSc, FACS
The Mount Sinai Hospital, Recanati/Miller Transplantation Institute New York, USA

Parissa Tabrizian, MD, MSc, FACS is a board-certified surgeon, Professor of Surgery who specializes in hepatobiliary and liver transplantation at the Recanati/Miller Transplantation Institute. Dr. Tabrizian earned her medical degree at the University of Vienna medical school and completed her general surgery residency at the Mount Sinai Medical Center in New York. She completed fellowships in surgical oncology and multiorgan transplant surgery at Mount Sinai Hospital. In 2015, Dr. Tabrizian obtained a master’s degree in clinical research from the Icahn School of Medicine, New York. Dr. Tabrizian performs a wide range of both open and minimally invasive procedures. Her research interests include hepatocellular carcinoma, cholangiocarcinoma, and liver transplantation. 
She has participated in large-scale projects, and collaborated with fellow researchers in this field, to produce numerous peer-reviewed publications. She was privileged to receive invitations to both national and international conferences to present her work. 

Dr Madhukar Patel (USA)
Medical Center, Texas, USA

Dr Madhukar Patel is an Associate Professor in the Department of Surgery at the UT Southwestern Medical Center. He is the Surgical Director of the UT Southwestern Liver Transplantation Program. As the Dedman Family Scholar in Clinical Care, Dr. Patel is actively involved in research focused on developing strategies to improve the number and quality of organs available for transplant.

Presented by